Yang, Bo <br/><br/>
Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial.  [electronic resource] 

 -  Hematological oncology  Sep 2012 
 - 115-22 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1099-1069 
<br/><br/><label>Standard No.: </label>10.1002/hon.1012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor<br/>Cells, Cultured--drug effects<br/>Comorbidity<br/>Cytokine-Induced Killer Cells--transplantation<br/>Female<br/>Hematologic Neoplasms--drug therapy<br/>Humans<br/>Immunotherapy, Adoptive<br/>Interferon-gamma--pharmacology<br/>Interleukin-2--pharmacology<br/>L-Lactate Dehydrogenase--blood<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Myelodysplastic Syndromes--drug therapy<br/>Pilot Projects<br/>Recombinant Proteins--pharmacology<br/>Remission Induction<br/>Salvage Therapy<br/>Thymopentin--pharmacology<br/>Treatment Outcome<br/>beta 2-Microglobulin--analysis